Search Results | Blood | American Society of Hematology

1-20 of 119

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Earlier Use of Zanubrutinib Monotherapy in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Is Associated with Greater Efficacy: A Pooled Analysis from 3 Studies

Blood (2020) 136 (Supplement 1): 36–37.

DOI: https://doi.org/10.1182/blood-2020-136236

Published: 2020

Journal Articles

Safety and Efficacy of the Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with WaldenstrC6m Macroglobulinemia from a Phase 2 Trial

Gang An, MD PhD, Daobin Zhou, MD PhD, Weili Zhao, MD PhD, Keshu Zhou, MD PhD, Jianyong Li, MD PhD, Jianfeng Zhou, MD PhD, Liping Xie, MD PhD, Jie Jin, MD PhD, Liye Zhong, MD PhD, Lingzhi Yan, MD PhD, Haiyi Guo, MD, Chenmu Du, MD, Jane Huang, MD, William Novotny, MD, Jinhua Zhong, PhD, Lugui Qiu, MD

Blood (2020) 136 (Supplement 1): 42–43.

DOI: https://doi.org/10.1182/blood-2020-136783

Published: 2020

Journal Articles

A Novel pH Dependent C5 Monoclonal Antibody with Better Developability

Lang Cheng, Run Zhang, Qi Gao, Haili Ma, Heng Liu, Guangsheng He, Prof.Dr., Jianyong Li, MD PhD

Blood (2020) 136 (Supplement 1): 11–12.

DOI: https://doi.org/10.1182/blood-2020-141787

Published: 2020

Journal Articles

Comparison of Subcutaneous Injection Versus Intravenous Infusion of Cytarabine for Induction Therapy in Young Adult Acute Myeloid Leukemia: Results of a Prospective, Multicenter, Noninferiority, Randomized Trial

Blood (2020) 136 (Supplement 1): 4.

DOI: https://doi.org/10.1182/blood-2020-143426

Published: 2020

Journal Articles

Ibrutinib Plus Fludarabine, Cyclophosphamide, and Rituximab As the Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia: A Single-Center Real World Study

Huayuan Zhu, Hui Shen, Yilian Yang, Chong-Yang Ding, MD, Yeqin Sha, Hongling Mi, Jingyan Qiu, Ruize Chen, Yujie Wu, Chun Qiao, Li Wang, MD, Lei Fan, MD PhD, Wei Xu, MD PhD, Jianyong Li, MD PhD

Blood (2020) 136 (Supplement 1): 29–30.

DOI: https://doi.org/10.1182/blood-2020-141747

Published: 2020

Journal Articles

Clinical Research: Treatment with Warfarin Followed By Hydroxyurea for Thrombosis Caused By JAK2 V617F -Positive Essential Thrombocythemia Associated with Mutation in the Thrombomodulin Gene and Deficiency of Protein S

Xingfu Sun, Jianxin Fu, MD PhD, Jianyong Li, MD PhD, Hua Lu, MD PhD

Blood (2020) 136 (Supplement 1): 14.

DOI: https://doi.org/10.1182/blood-2020-136087

Published: 2020

Journal Articles

Updated Results from the Phase II Study of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia

Blood (2020) 136 (Supplement 1): 26–27.

DOI: https://doi.org/10.1182/blood-2020-134531

Published: 2020

Journal Articles

An Anti-Bcma CAR T-Cell Therapy (C-CAR088) Shows Promising Safety and Efficacy Profile in Relapsed or Refractory Multiple Myeloma

Blood (2020) 136 (Supplement 1): 29–30.

DOI: https://doi.org/10.1182/blood-2020-138734

Published: 2020

Journal Articles

Functional Evaluation and Mechanism Study of Kel As an Oncogenic Driver in Acute Erythroleukemia

Hui Jin, Jianyong Li, MD, Zijuan Wu, Handong Sun, Wenjie Liu, MD, Yanfeng Liu, PhD, Ming Hong, MD PhD, Sixuan Qian, Wei Xu, MD PhD

Blood (2019) 134 (Supplement_1): 1246.

DOI: https://doi.org/10.1182/blood-2019-124607

Published: 2019

Journal Articles

PTBP1 Regulates Alternative Splicing of Apoptotic Protein: Implications in CLL and Ibrutinib Resistance

Huayuan Zhu, Xiaotong Li, Xinqi Zheng, Juejin Wang, Hanning Tang, Wei Xu, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 1290.

DOI: https://doi.org/10.1182/blood-2019-126945

Published: 2019

Journal Articles

Mitochondrial Genome-Derived Mc-COX2 with Novel Characteristics Predicts Prognosis of Patients with Chronic Lymphocytic Leukemia

Hui Jin, Jianyong Li, MD, Zijuan Wu, Handong Sun, Yi Xia, Jianxin Fu, MD PhD, Lei Fan, MD PhD, Wei Xu, MD PhD, Li Wang, MD

Blood (2019) 134 (Supplement_1): 4284.

DOI: https://doi.org/10.1182/blood-2019-124609

Published: 2019

Journal Articles

A Phase 3 Trial Comparing the Efficacy and Safety of Acalabrutinib in Combination with Venetoclax with or without Obinutuzumab, Compared with Investigator's Choice of Chemoimmunotherapy in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) without Del(17p) or TP53 Mutation

Jennifer R Brown, MD PhD, Barbara F. Eichhorst, MD, Paolo Ghia, MD PhD, Arnon P. Kater, MD PhD, Jianyong Li, MD, Sudha Khurana, Mostafa Elhamy, Min Hui Wang, PhD, John F. Seymour, MBBS, PhD FRACP

Blood (2019) 134 (Supplement_1): 4318.

DOI: https://doi.org/10.1182/blood-2019-123057

Published: 2019

Journal Articles

Safety, Tolerability and Efficacy of Orelabrutinib, Once a Day, to Treat Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia

Blood (2019) 134 (Supplement_1): 4319.

DOI: https://doi.org/10.1182/blood-2019-123331

Published: 2019

Journal Articles

Preliminary Results from a Phase I Study of SHC014748M in Patients with Relapsed or Refractory Indolent B-Cell Lymphomas

Wei Xu, MD PhD, Jie Jin, MD PhD, Keshu Zhou, MD, Li Wang, MD, Huayuan Zhu, Jiejing Qian, Jianying Huang, Fuling Zhou, MD, Xiaohong Xu, Zhiqiang Wang, Wei Guo, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 4000.

DOI: https://doi.org/10.1182/blood-2019-126707

Published: 2019

Journal Articles

Myeloid Tumor-Related Somatic Mutations in 293 Children and Adults with Acquired Aplastic Anemia in Chinese

Hailong He, MD, Hua Yin, Xiaoqing Liu, Lang Cheng, Guangsheng He, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 5024.

DOI: https://doi.org/10.1182/blood-2019-129813

Published: 2019

Journal Articles

SHC014748M, a Novel Selective Inhibitor of PI3Kδ, Demonstrates Promising Pre-Clinical Antitumor Activity in B Cell Lymphomas and CLL

Lei Fan, MD PhD, Chao Wang, Zhiqiang Wang, Xian Zhang, Lei Cao, Yi Miao, MD PhD, Xinyi Du, Wei Xu, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 5306.

DOI: https://doi.org/10.1182/blood-2019-129469

Published: 2019

Journal Articles

Association of Insurance Status and Marital Status with Outcomes of Patients with Chronic Lymphocytic Leukemia: A Population-Based Study

Yi Miao, MD PhD, Wei Xu, MD PhD, Lei Fan, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 5459.

DOI: https://doi.org/10.1182/blood-2019-127756

Published: 2019

Journal Articles

TP53 Abnormality in Myelodysplastic Syndrome

Fei Huang, Yu Chen, Yuxing Zhu, Chun Qiao, Sixuan Qian, Jianyong Li, MD, Wenyi Shen, MD

Blood (2019) 134 (Supplement_1): 5410.

DOI: https://doi.org/10.1182/blood-2019-128054

Published: 2019

Journal Articles

Circ-RPL15: A Plasma Circular RNA As Novel Oncogenic Driver to Promote Progression of Chronic Lymphocytic Leukemia

Hui Jin, Handong Sun, Zijuan Wu, Yi Xia, Jianxin Fu, MD PhD, Wei Xu, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 3020.

DOI: https://doi.org/10.1182/blood-2019-126610

Published: 2019

Journal Articles

Laterality and Survival Outcomes in Patients with Primary Testicular Diffuse Large B Cell Lymphoma

Yi Miao, MD PhD, Lei Fan, MD PhD, Wei Xu, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 2903.

DOI: https://doi.org/10.1182/blood-2019-129952

Published: 2019

2 3 4 5

NARROW

Earlier Use of Zanubrutinib Monotherapy in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Is Associated with Greater Efficacy: A Pooled Analysis from 3 Studies

Safety and Efficacy of the Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with WaldenstrC6m Macroglobulinemia from a Phase 2 Trial

A Novel pH Dependent C5 Monoclonal Antibody with Better Developability

Comparison of Subcutaneous Injection Versus Intravenous Infusion of Cytarabine for Induction Therapy in Young Adult Acute Myeloid Leukemia: Results of a Prospective, Multicenter, Noninferiority, Randomized Trial

Ibrutinib Plus Fludarabine, Cyclophosphamide, and Rituximab As the Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia: A Single-Center Real World Study

Clinical Research: Treatment with Warfarin Followed By Hydroxyurea for Thrombosis Caused By JAK2 V617F -Positive Essential Thrombocythemia Associated with Mutation in the Thrombomodulin Gene and Deficiency of Protein S

Updated Results from the Phase II Study of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia

An Anti-Bcma CAR T-Cell Therapy (C-CAR088) Shows Promising Safety and Efficacy Profile in Relapsed or Refractory Multiple Myeloma

Functional Evaluation and Mechanism Study of Kel As an Oncogenic Driver in Acute Erythroleukemia

PTBP1 Regulates Alternative Splicing of Apoptotic Protein: Implications in CLL and Ibrutinib Resistance

Mitochondrial Genome-Derived Mc-COX2 with Novel Characteristics Predicts Prognosis of Patients with Chronic Lymphocytic Leukemia

A Phase 3 Trial Comparing the Efficacy and Safety of Acalabrutinib in Combination with Venetoclax with or without Obinutuzumab, Compared with Investigator's Choice of Chemoimmunotherapy in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) without Del(17p) or TP53 Mutation

Safety, Tolerability and Efficacy of Orelabrutinib, Once a Day, to Treat Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia

Preliminary Results from a Phase I Study of SHC014748M in Patients with Relapsed or Refractory Indolent B-Cell Lymphomas

Myeloid Tumor-Related Somatic Mutations in 293 Children and Adults with Acquired Aplastic Anemia in Chinese

SHC014748M, a Novel Selective Inhibitor of PI3Kδ, Demonstrates Promising Pre-Clinical Antitumor Activity in B Cell Lymphomas and CLL

Association of Insurance Status and Marital Status with Outcomes of Patients with Chronic Lymphocytic Leukemia: A Population-Based Study

TP53 Abnormality in Myelodysplastic Syndrome

Circ-RPL15: A Plasma Circular RNA As Novel Oncogenic Driver to Promote Progression of Chronic Lymphocytic Leukemia

Laterality and Survival Outcomes in Patients with Primary Testicular Diffuse Large B Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only